Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase is a phase 1/2, interventional study registered as NCT04195347 by St. Jude Children's Research Hospital, with a registry enrolment figure of 42 participants, started 2020-09-04 and due to reach its primary completion in 2027-01. Interventions recorded: CM4620. Conditions listed: Acute Pancreatitis. Primary outcome: The number of CTCAE grade 3-5 events; Responses to CM4620. Pancreatic eligibility wording from the registry: "* Acute pancreatitis with elevation of amylase OR lipase ≥ 3x the upper limit of normal AND at least 1 of: abdominal pain consistent with acute pancreatitis OR imaging findings consistent with acute pancreatitis". Sites: United States. No results are recorded here; the registry entry is the source.